733 related articles for article (PubMed ID: 9185968)
1. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
Myers NC; Andrews GA; Chard-Bergstrom C
Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo).
Andrews GA; Myers NC; Chard-Bergstrom C
Vet Pathol; 1997 Sep; 34(5):387-93. PubMed ID: 9381649
[TBL] [Abstract][Full Text] [Related]
3. Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas?
Wiesli P; Uthoff H; Perren A; Pfammatter T; Zwimpfer C; Seiler H; Kindhauser R; Spinas GA; Schmid C
Pancreas; 2011 Oct; 40(7):995-9. PubMed ID: 21705951
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of pancreatic neuroendocrine tumor in Panthera tigris tigris.
Nyska A; Goldstein J; Eshkar G; Klein B
J Wildl Dis; 1996 Jul; 32(3):541-4. PubMed ID: 8827685
[TBL] [Abstract][Full Text] [Related]
5. Validation of a rapid solid-phase radioimmunoassay for canine, bovine, and equine insulin.
Reimers TJ; Cowan RG; McCann JP; Ross MW
Am J Vet Res; 1982 Jul; 43(7):1274-8. PubMed ID: 6285776
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic endocrine carcinoma with multiple hormone production in a raccoon (Procyon lotor).
Yoshikawa K; Matsuura S; Tsuchiya T; Kadota K
J Comp Pathol; 1999 Apr; 120(3):301-6. PubMed ID: 10213674
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
8. Chromostatin, a chromogranin A-derived bioactive peptide, is present in human pancreatic insulin (beta) cells.
Cetin Y; Aunis D; Bader MF; Galindo E; Jörns A; Bargsten G; Grube D
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2360-4. PubMed ID: 8096340
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular characterization of a feline insulinoma.
Jackson TC; Debey B; Lindbloom-Hawley S; Jones BT; Schermerhorn T
J Vet Intern Med; 2009; 23(2):383-7. PubMed ID: 19192149
[TBL] [Abstract][Full Text] [Related]
10. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
11. The importance of chromogranin A in the development and function of endocrine pancreas.
Portela-Gomes GM; Gayen JR; Grimelius L; Stridsberg M; Mahata SK
Regul Pept; 2008 Nov; 151(1-3):19-25. PubMed ID: 18722481
[TBL] [Abstract][Full Text] [Related]
12. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study].
Eberlein-Gonska M; Wiedenmann B; Waldherr R
Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534
[No Abstract] [Full Text] [Related]
13. Synaptophysin. A new marker for pancreatic neuroendocrine tumors.
Chejfec G; Falkmer S; Grimelius L; Jacobsson B; Rodensjö M; Wiedenmann B; Franke WW; Lee I; Gould VE
Am J Surg Pathol; 1987 Apr; 11(4):241-7. PubMed ID: 3032010
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical demonstration of chromogranin A in endocrine organs of the rat and horse by use of region-specific antibodies.
Hashimoto Y; Ohki H; Sato F; Yanaihara N; Iwanaga T
Jpn J Vet Res; 2001 May; 49(1):3-17. PubMed ID: 11521446
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemistry of normal pancreatic islets and spontaneous islet cell tumors in dogs.
Hawkins KL; Summers BA; Kuhajda FP; Smith CA
Vet Pathol; 1987 Mar; 24(2):170-9. PubMed ID: 2883753
[TBL] [Abstract][Full Text] [Related]
16. Insulin-secreting tumor: diagnosis and medical and surgical management in 55 dogs.
Leifer CE; Peterson ME; Matus RE
J Am Vet Med Assoc; 1986 Jan; 188(1):60-4. PubMed ID: 3003016
[TBL] [Abstract][Full Text] [Related]
17. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
18. Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.
Woltering EA; Hilton RS; Zolfoghary CM; Thomson J; Zietz S; Go VL; Vinik AI; Vinik E; O'Dorisio TM; Mamikunian G
Pancreas; 2006 Oct; 33(3):250-4. PubMed ID: 17003646
[TBL] [Abstract][Full Text] [Related]
19. Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study.
Jirásek T; Hozák P; Mandys V
Neoplasma; 2003; 50(1):1-7. PubMed ID: 12687271
[TBL] [Abstract][Full Text] [Related]
20. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
